PANEL 06 // THE QUESTION INDEX
BPC-157 TB-500 FAQ, answered from the record
Direct answers on the Wolverine blend — definition, mechanism, dose context, safety, and the regulatory record — each scanned to its source where it makes a quantitative claim.
Definition and difference
These answers cover what the BPC-157 TB-500 blend is, what its constituents are, and how they differ. Each is a direct answer first, context second.
Mechanism and combination
These answers cover how each peptide works and what the "synergy" of the combination does — and does not — rest on.
Evidence and efficacy
These answers cover the tissue-specific findings and the human-data record, with the consistent flag that the evidence is single-compound and largely rodent.
Dose, route, and handling
These answers cover the practical dosing and reconstitution questions, with the same flag throughout: no validated dose for the blend.
Safety and the tumor signal
These answers cover the safety questions honestly: no controlled human safety data for the blend, and a real theoretical concern around Thymosin Beta-4.
Regulatory and access
These answers summarize the regulatory record; the Wolverine legal status and FDA 503A category page covers it in full and cites FDA.